|
|
| MRD / Regn No. |
: 20210001179 |
Date |
: 18/07/2026 |
| Patient Name |
: Deben Chandra Das |
Age & Gender |
: 62 Yrs. / Male |
| Contact No. |
: 9435384322 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DM (16/Nov/2021) | HYPERTENSION (16/Nov/2015) | A2G2 DKD (19/Nov/2021) | DYSLIPIDEMIA (19/Nov/2021) | |
|
Subjective |
: |
HYPERTENSION FOR 6 YEARS,TYPE 2 DM FOR 5 YEARS,LOST TO FOLLOW UP |
|
Objective |
: |
NONE |
|
Analysis |
: |
HYPERTENSION,TYPE 2 DM,UTI,A2G2 DKD,DYSLIPIDEMIA,VITAMIN D DEFICIENCY,ANEMIA,MILD TSH ELEVATION,HEART FAILURE STAGE B,A2G3 DKD,DR CHANGES IN FUNDUS |
|
Plan |
: |
GET ADDITIONAL TESTING,OPHTHALMOLOGY OPINION |
|
| Salient Investigations |
: |
CUP DISC RATIO L: 0.67 | CUP DISK RATIO R: 0.63 | ABI LEFT: 1.07 | ABI RIGHT: 1.12 | HEMOGLOBIN: 10.2 g/dL | MCH: 23 pg | MCHC: 32 gm % | MCV: 72 fl | PCV: 32 % | PLATELETS: 130 thou cells/ ul | RBC COUNT: 4.46 million/ul | TOTAL COUNT WBC: 9.24 Cells/cmm | VITAMIN D (25 OH): 9.9 ng/mL | NT PROBNP : 780 pg/mL | FREE T4 : 1.22 ng/dL | TSH : 5.170 mIU/L | FASTING PLASMA GLUCOSE (FPG): 361 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 11.8 % | POST PRANDIAL GLUCOSE (2HPP): 552 mg/dL | CREATININE: 1.68 mg/dL | HIGH SENSITIVE C REACTIVE PROTEIN: 2.60 mg/L | BUN BLOOD UREA NITROGEN: 24.6 mg/dL | UREA: 53 mg/dL | A\G RATIO: 0.99 g/dl | ALBUMIN (SERUM): 3.57 g/dL | ALKALINE PHOSPHOTASE: 135 IU/L | DIRECT BILIRUBIN: 0.12 mg/dl | GAMMA GLUTAMYL TRANSFERASE (GGT): 33 U/L | GLOBULIN: 3.59 g/dl | INDIRECT BILIRUBIN: 0.22 | SGOT (AST): 22 U/L | SGPT (ALT): 24 IU/L | TOTAL BILIRUBIN: 0.34 mg/dL | TOTAL PROTEIN: 7.16 g/dl | EGFR EGLOMERULAR FILTRATION RATE: 44.37 mL/min/1.73m2 | EGFR EGLOMERULAR FILTRATION RATE: 44.37 mL/min/1.73m2 | FIB4: 2.14 | FIB4: 2.14 | HDL HIGH DENSITY LIPOPROTEIN: 46 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 180 mg/dL | TGL TRIGLYCERIDE: 181 mg/dL | TOTAL CHO/HDL RATIO: 5.5 | TOTAL CHOLESTEROL: 253 mg/dl | VLDL: 36 mg/dl | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TELMISARTAN 40 MG HYDROCHLORTHIAZIDE 12.5 MG
ERITEL H 40 |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
|
|
2 |
GLICLAZIDE MR 30 MG
DIAMCIRON MR 30 MG |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
3 |
SITAGLIPTIN/METFORMIN 50/500 MG
JANUMET 50/500 MG |
PO |
1-0-1 |
BEFORE FOOD
|
TILL NEXT VISIT |
|
|
4 |
ROSUVASTATIN 10 MG
CRESTOR 10 MG |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 17/Aug/2026 |
| Tests Suggested For Next Visit |
: 2D ECHO OF THE HEART PLEASE CALCULATE EE' AND GLS |
| |
|
| |
|
|
